1
|
Ramírez-Toloza G, Aguilar-Guzmán L, Valck C, Menon SS, Ferreira VP, Ferreira A. Is It Possible to Intervene in the Capacity of Trypanosoma cruzi to Elicit and Evade the Complement System? Front Immunol 2021; 12:789145. [PMID: 34975884 PMCID: PMC8716602 DOI: 10.3389/fimmu.2021.789145] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2021] [Accepted: 11/19/2021] [Indexed: 11/23/2022] Open
Abstract
Chagas' disease is a zoonotic parasitic ailment now affecting more than 6 million people, mainly in Latin America. Its agent, the protozoan Trypanosoma cruzi, is primarily transmitted by endemic hematophagous triatomine insects. Transplacental transmission is also important and a main source for the emerging global expansion of this disease. In the host, the parasite undergoes intra (amastigotes) and extracellular infective (trypomastigotes) stages, both eliciting complex immune responses that, in about 70% of the cases, culminate in permanent immunity, concomitant with the asymptomatic presence of the parasite. The remaining 30% of those infected individuals will develop a syndrome, with variable pathological effects on the circulatory, nervous, and digestive systems. Herein, we review an important number of T. cruzi molecules, mainly located on its surface, that have been characterized as immunogenic and protective in various experimental setups. We also discuss a variety of parasite strategies to evade the complement system - mediated immune responses. Within this context, we also discuss the capacity of the T. cruzi infective trypomastigote to translocate the ER-resident chaperone calreticulin to its surface as a key evasive strategy. Herein, it is described that T. cruzi calreticulin inhibits the initial stages of activation of the host complement system, with obvious benefits for the parasite. Finally, we speculate on the possibility to experimentally intervene in the interaction of calreticulin and other T. cruzi molecules that interact with the complement system; thus resulting in significant inhibition of T. cruzi infectivity.
Collapse
Affiliation(s)
- Galia Ramírez-Toloza
- Department of Preventive Veterinary Medicine, Faculty of Veterinary Medicine and Livestock Sciences, University of Chile, Santiago, Chile
| | - Lorena Aguilar-Guzmán
- Department of Pathology, Faculty of Veterinary Medicine and Livestock Sciences, University of Chile, Santiago, Chile
| | - Carolina Valck
- Department of Immunology, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile, Santiago, Chile
| | - Smrithi S. Menon
- Department of Medical Microbiology and Immunology, College of Medicine and Life Sciences, University of Toledo, Toledo, OH, United States
| | - Viviana P. Ferreira
- Department of Medical Microbiology and Immunology, College of Medicine and Life Sciences, University of Toledo, Toledo, OH, United States
| | - Arturo Ferreira
- Department of Immunology, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile, Santiago, Chile
| |
Collapse
|
2
|
Ramírez-Toloza G, Aguilar-Guzmán L, Valck C, Ferreira VP, Ferreira A. The Interactions of Parasite Calreticulin With Initial Complement Components: Consequences in Immunity and Virulence. Front Immunol 2020; 11:1561. [PMID: 32793217 PMCID: PMC7391170 DOI: 10.3389/fimmu.2020.01561] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2020] [Accepted: 06/12/2020] [Indexed: 12/17/2022] Open
Abstract
Because of its capacity to increase a physiologic inflammatory response, to stimulate phagocytosis, to promote cell lysis and to enhance pathogen immunogenicity, the complement system is a crucial component of both the innate and adaptive immune responses. However, many infectious agents resist the activation of this system by expressing or secreting proteins with a role as complement regulatory, mainly inhibitory, proteins. Trypanosoma cruzi, the causal agent of Chagas disease, a reemerging microbial ailment, possesses several virulence factors with capacity to inhibit complement at different stages of activation. T. cruzi calreticulin (TcCalr) is a highly-conserved, endoplasmic reticulum-resident chaperone that the parasite translocates to the extracellular environment, where it exerts a variety of functions. Among these functions, TcCalr binds C1, MBL and ficolins, thus inhibiting the classical and lectin pathways of complement at their earliest stages of activation. Moreover, the TcCalr/C1 interaction also mediates infectivity by mimicking a strategy used by apoptotic cells for their removal. More recently, it has been determined that these Calr strategies are also used by a variety of other parasites. In addition, as reviewed elsewhere, TcCalr inhibits angiogenesis, promotes wound healing and reduces tumor growth. Complement C1 is also involved in some of these properties. Knowledge on the role of virulence factors, such as TcCalr, and their interactions with complement components in host-parasite interactions, may lead toward the description of new anti-parasite therapies and prophylaxis.
Collapse
Affiliation(s)
- Galia Ramírez-Toloza
- Department of Preventive Veterinary Medicine, Faculty of Veterinary Medicine and Livestock Sciences, University of Chile, Santiago, Chile
| | - Lorena Aguilar-Guzmán
- Department of Pathology, Faculty of Veterinary Medicine and Livestock Sciences, University of Chile, Santiago, Chile
| | - Carolina Valck
- Department of Immunology, ICBM, Faculty of Medicine, University of Chile, Santiago, Chile
| | - Viviana P Ferreira
- Department of Medical Microbiology and Immunology, College of Medicine and Life Sciences, University of Toledo, Toledo, OH, United States
| | - Arturo Ferreira
- Department of Immunology, ICBM, Faculty of Medicine, University of Chile, Santiago, Chile
| |
Collapse
|
3
|
Sosoniuk-Roche E, Cruz P, Maldonado I, Duaso L, Pesce B, Michalak M, Valck C, Ferreira A. In vitro Treatment of a Murine Mammary Adenocarcinoma Cell Line with Recombinant Trypanosoma cruzi Calreticulin Promotes Immunogenicity and Phagocytosis. Mol Immunol 2020; 124:51-60. [PMID: 32526557 DOI: 10.1016/j.molimm.2020.05.013] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2019] [Revised: 04/16/2020] [Accepted: 05/11/2020] [Indexed: 12/11/2022]
Abstract
American Trypanosomiasis, a parasitic disease produced by Trypanosoma cruzi (T. cruzi), endemic in Latin America, infects about 6 million people. During the chronic stage of the infection, approximately 30% of infected people will develop Chagas Disease, the clinical manifestation. Few decades ago it was reported that, during the chronic stage, the parasite interferes with the development of solid tumors. However, the identification of parasite molecules responsible for such effects remained elusive. Years later, we described T.cruzi Calreticulin (TcCalr), an endoplasmic reticulum resident chaperone that infective trypomastigotes translocate to the parasite exterior, where it displays anticomplement activities. Most likely, at least some of these activities are related with the antitumor properties of TcCalr, as shown in in vitro, ex vivo, in ovum, and in vivo models. In this context we, we have seen that in vivo subcutaneous peritumoral inoculation of rTcCalr enhances local infiltration of T cells and slows tumor development. Based on these precedents, we propose that in vitro treatment of a mammary adenocarcinoma (TA3 cell line) with rTcCalr, will enhance tumor immunogenicity. In agreement with this proposal, we have shown that: i). rTcCalr binds to TA3 cells in a concentration-dependent fashion, ii). C1q binds to TA3 cells in an rTcCalr-dependent fashion, confirmed by the reversion attained using anti-TcS (a central TcCalr domain that binds C1) F(ab')2 antibody fragments, iii). incubation of TA3 cells with rTcCalr, promotes cell phagocytosis by murine macrophages and, iv). rTcCalr decreases the membrane expression of MHC class II, m-Dectin-1, Galectin-9 and PD-L1, while increasing the expression of Rae-1γ. In synthesis, herein we show that in vitro treatment of a murine mammary adenocarcinoma with rTcCalr enhances phagocytosis and modulates the expression of a variety of membrane molecules that correlates with increased tumor immunogenicity.
Collapse
Affiliation(s)
- Eduardo Sosoniuk-Roche
- Immunology of Microbial Aggressions, Immunology Disciplinary Program, Biomedical Science Institute, Faculty of Medicine, Universidad de Chile, Chile
| | - Pamela Cruz
- Immunology of Microbial Aggressions, Immunology Disciplinary Program, Biomedical Science Institute, Faculty of Medicine, Universidad de Chile, Chile
| | - Ismael Maldonado
- Immunology of Microbial Aggressions, Immunology Disciplinary Program, Biomedical Science Institute, Faculty of Medicine, Universidad de Chile, Chile
| | - Leonora Duaso
- Immunology of Microbial Aggressions, Immunology Disciplinary Program, Biomedical Science Institute, Faculty of Medicine, Universidad de Chile, Chile
| | - Bárbara Pesce
- MED.UCHILE-FACS Laboratory, Biomedical Science Institute, Faculty of Medicine, Universidad de Chile, Chile
| | - Marek Michalak
- Department of Biochemistry, University of Alberta, Alberta, Canada
| | - Carolina Valck
- Immune Response Modulation by the Complement System, Immunology Disciplinary Program, Biomedical Science Institute, Faculty of Medicine, Universidad de Chile, Chile.
| | - Arturo Ferreira
- Immunology of Microbial Aggressions, Immunology Disciplinary Program, Biomedical Science Institute, Faculty of Medicine, Universidad de Chile, Chile.
| |
Collapse
|
4
|
Ramírez-Toloza G, Sosoniuk-Roche E, Valck C, Aguilar-Guzmán L, Ferreira VP, Ferreira A. Trypanosoma cruzi Calreticulin: Immune Evasion, Infectivity, and Tumorigenesis. Trends Parasitol 2020; 36:368-381. [PMID: 32191851 DOI: 10.1016/j.pt.2020.01.007] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2019] [Revised: 01/25/2020] [Accepted: 01/26/2020] [Indexed: 02/06/2023]
Abstract
To successfully infect, Trypanosoma cruzi evades and modulates the host immune response. T. cruzi calreticulin (TcCalr) is a multifunctional, endoplasmic reticulum (ER)-resident chaperone that, translocated to the external microenvironment, mediates crucial host-parasite interactions. TcCalr binds and inactivates C1 and mannose-binding lectin (MBL)/ficolins, important pattern- recognition receptors (PRRs) of the complement system. Using an apoptotic mimicry strategy, the C1-TcCalr association facilitates the infection of target cells. T. cruzi infection also seems to confer protection against tumorigenesis. Thus, recombinant TcCalr has important antiangiogenic properties, detected in vitro, ex vivo, and in ovum, most likely contributing at least in part, to its antitumor properties. Consequently, TcCalr is useful for investigating key issues of host-parasite interactions and possible new immunological/pharmacological interventions in the areas of Chagas' disease and experimental cancer.
Collapse
Affiliation(s)
- Galia Ramírez-Toloza
- Faculty of Veterinary Medicine and Livestock Sciences, University of Chile, Santiago, Chile.
| | | | - Carolina Valck
- Department of Immunology, Faculty of Medicine, University of Chile, Santiago, Chile
| | - Lorena Aguilar-Guzmán
- Faculty of Veterinary Medicine and Livestock Sciences, University of Chile, Santiago, Chile
| | - Viviana P Ferreira
- Department of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, OH, USA
| | - Arturo Ferreira
- Department of Immunology, Faculty of Medicine, University of Chile, Santiago, Chile.
| |
Collapse
|
5
|
Pizarro-Bauerle J, Maldonado I, Sosoniuk-Roche E, Vallejos G, López MN, Salazar-Onfray F, Aguilar-Guzmán L, Valck C, Ferreira A, Becker MI. Molluskan Hemocyanins Activate the Classical Pathway of the Human Complement System through Natural Antibodies. Front Immunol 2017; 8:188. [PMID: 28286504 PMCID: PMC5323374 DOI: 10.3389/fimmu.2017.00188] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2016] [Accepted: 02/09/2017] [Indexed: 11/18/2022] Open
Abstract
Molluskan hemocyanins are enormous oxygen-carrier glycoproteins that show remarkable immunostimulatory properties when inoculated in mammals, such as the generation of high levels of antibodies, a strong cellular reaction, and generation of non-specific antitumor immune responses in some types of cancer, particularly for superficial bladder cancer. These proteins have the ability to bias the immune response toward a Th1 phenotype. However, despite all their current uses with beneficial clinical outcomes, a clear mechanism explaining these properties is not available. Taking into account reports of natural antibodies against the hemocyanin of the gastropod Megathura crenulata [keyhole limpet hemocyanin (KLH)] in humans as well as other vertebrate species, we report here for the first time, the presence, in sera from unimmunized healthy donors, of antibodies recognizing, in addition to KLH, two other hemocyanins from gastropods with documented immunomodulatory capacities: Fisurella latimarginata hemocyanin (FLH) and Concholepas concholepas hemocyanin (CCH). Through an ELISA screening, we found IgM and IgG antibodies reactive with these hemocyanins. When the capacity of these antibodies to bind deglycosylated hemocyanins was studied, no decreased interaction was detected. Moreover, in the case of FLH, deglycosylation increased antibody binding. We evaluated through an in vitro complement deposition assay whether these antibodies activated the classical pathway of the human complement system. The results showed that all three hemocyanins and their deglycosylated counterparts elicited this activation, mediated by C1 binding to immunoglobulins. Thus, this work contributes to the understanding on how the complement system could participate in the immunostimulatory properties of hemocyanins, through natural, complement-activating antibodies reacting with these proteins. Although a role for carbohydrates cannot be completely ruled out, in our experimental setting, glycosylation status had a limited effect. Finally, our data open possibilities for further studies leading to the design of improved hemocyanin-based research tools for diagnosis and immunotherapy.
Collapse
Affiliation(s)
- Javier Pizarro-Bauerle
- Immunology of Microbial Aggression Laboratory, Immunology Program, Faculty of Medicine, ICBM, Universidad de Chile , Santiago , Chile
| | - Ismael Maldonado
- Immunology of Microbial Aggression Laboratory, Immunology Program, Faculty of Medicine, ICBM, Universidad de Chile , Santiago , Chile
| | - Eduardo Sosoniuk-Roche
- Immunology of Microbial Aggression Laboratory, Immunology Program, Faculty of Medicine, ICBM, Universidad de Chile , Santiago , Chile
| | - Gerardo Vallejos
- Immunology of Microbial Aggression Laboratory, Immunology Program, Faculty of Medicine, ICBM, Universidad de Chile , Santiago , Chile
| | - Mercedes N López
- Faculty of Medicine, Millennium Institute on Immunology and Immunotherapy, ICBM, Universidad de Chile, Santiago, Chile; Immunology Program, Faculty of Medicine, ICBM, Universidad de Chile, Santiago, Chile
| | - Flavio Salazar-Onfray
- Faculty of Medicine, Millennium Institute on Immunology and Immunotherapy, ICBM, Universidad de Chile, Santiago, Chile; Immunology Program, Faculty of Medicine, ICBM, Universidad de Chile, Santiago, Chile
| | - Lorena Aguilar-Guzmán
- Faculty of Veterinary Medicine and Livestock Sciences, University of Chile , Santiago , Chile
| | - Carolina Valck
- Immunology of Microbial Aggression Laboratory, Immunology Program, Faculty of Medicine, ICBM, Universidad de Chile , Santiago , Chile
| | - Arturo Ferreira
- Immunology of Microbial Aggression Laboratory, Immunology Program, Faculty of Medicine, ICBM, Universidad de Chile , Santiago , Chile
| | - María Inés Becker
- Biosonda Corporation, Santiago, Chile; Fundación Ciencia y Tecnología para el Desarrollo (FUCITED), Santiago, Chile
| |
Collapse
|
6
|
González A, Valck C, Sánchez G, Härtel S, Mansilla J, Ramírez G, Fernández MS, Arias JL, Galanti N, Ferreira A. Trypanosoma cruzi Calreticulin Topographical Variations in Parasites Infecting Murine Macrophages. Am J Trop Med Hyg 2015; 92:887-97. [PMID: 25758653 DOI: 10.4269/ajtmh.14-0497] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2014] [Accepted: 12/29/2014] [Indexed: 11/07/2022] Open
Abstract
Trypanosoma cruzi calreticulin (TcCRT), a 47-kDa chaperone, translocates from the endoplasmic reticulum to the area of flagellum emergence. There, it binds to complement components C1 and mannan-binding lectin (MBL), thus acting as a main virulence factor, and inhibits the classical and lectin pathways. The localization and functions of TcCRT, once the parasite is inside the host cell, are unknown. In parasites infecting murine macrophages, polyclonal anti-TcCRT antibodies detected TcCRT mainly in the parasite nucleus and kinetoplast. However, with a monoclonal antibody (E2G7), the resolution and specificity of the label markedly improved, and TcCRT was detected mainly in the parasite kinetoplast. Gold particles, bound to the respective antibodies, were used as probes in electron microscopy. This organelle may represent a stopover and accumulation site for TcCRT, previous its translocation to the area of flagellum emergence. Finally, early during T. cruzi infection and by unknown mechanisms, an important decrease in the number of MHC-I positive host cells was observed.
Collapse
Affiliation(s)
- Andrea González
- Programa Disciplinario de Inmunología, Programa de Genética Humana, Programa de Biología Celular y Molecular, Instituto de Ciencias Biomédicas; Laboratorio de Análisis de Imágenes Científicas (SCIAN), Instituto de Neurociencias Biomédicas, Facultad de Medicina; Departamento de Medicina Preventiva Animal, Departamento de Ciencias Biológicas Animales, Facultad de Ciencias Veterinarias y Pecuarias, Universidad de Chile, Chile
| | - Carolina Valck
- Programa Disciplinario de Inmunología, Programa de Genética Humana, Programa de Biología Celular y Molecular, Instituto de Ciencias Biomédicas; Laboratorio de Análisis de Imágenes Científicas (SCIAN), Instituto de Neurociencias Biomédicas, Facultad de Medicina; Departamento de Medicina Preventiva Animal, Departamento de Ciencias Biológicas Animales, Facultad de Ciencias Veterinarias y Pecuarias, Universidad de Chile, Chile
| | - Gittith Sánchez
- Programa Disciplinario de Inmunología, Programa de Genética Humana, Programa de Biología Celular y Molecular, Instituto de Ciencias Biomédicas; Laboratorio de Análisis de Imágenes Científicas (SCIAN), Instituto de Neurociencias Biomédicas, Facultad de Medicina; Departamento de Medicina Preventiva Animal, Departamento de Ciencias Biológicas Animales, Facultad de Ciencias Veterinarias y Pecuarias, Universidad de Chile, Chile
| | - Steffen Härtel
- Programa Disciplinario de Inmunología, Programa de Genética Humana, Programa de Biología Celular y Molecular, Instituto de Ciencias Biomédicas; Laboratorio de Análisis de Imágenes Científicas (SCIAN), Instituto de Neurociencias Biomédicas, Facultad de Medicina; Departamento de Medicina Preventiva Animal, Departamento de Ciencias Biológicas Animales, Facultad de Ciencias Veterinarias y Pecuarias, Universidad de Chile, Chile
| | - Jorge Mansilla
- Programa Disciplinario de Inmunología, Programa de Genética Humana, Programa de Biología Celular y Molecular, Instituto de Ciencias Biomédicas; Laboratorio de Análisis de Imágenes Científicas (SCIAN), Instituto de Neurociencias Biomédicas, Facultad de Medicina; Departamento de Medicina Preventiva Animal, Departamento de Ciencias Biológicas Animales, Facultad de Ciencias Veterinarias y Pecuarias, Universidad de Chile, Chile
| | - Galia Ramírez
- Programa Disciplinario de Inmunología, Programa de Genética Humana, Programa de Biología Celular y Molecular, Instituto de Ciencias Biomédicas; Laboratorio de Análisis de Imágenes Científicas (SCIAN), Instituto de Neurociencias Biomédicas, Facultad de Medicina; Departamento de Medicina Preventiva Animal, Departamento de Ciencias Biológicas Animales, Facultad de Ciencias Veterinarias y Pecuarias, Universidad de Chile, Chile
| | - María Soledad Fernández
- Programa Disciplinario de Inmunología, Programa de Genética Humana, Programa de Biología Celular y Molecular, Instituto de Ciencias Biomédicas; Laboratorio de Análisis de Imágenes Científicas (SCIAN), Instituto de Neurociencias Biomédicas, Facultad de Medicina; Departamento de Medicina Preventiva Animal, Departamento de Ciencias Biológicas Animales, Facultad de Ciencias Veterinarias y Pecuarias, Universidad de Chile, Chile
| | - José Luis Arias
- Programa Disciplinario de Inmunología, Programa de Genética Humana, Programa de Biología Celular y Molecular, Instituto de Ciencias Biomédicas; Laboratorio de Análisis de Imágenes Científicas (SCIAN), Instituto de Neurociencias Biomédicas, Facultad de Medicina; Departamento de Medicina Preventiva Animal, Departamento de Ciencias Biológicas Animales, Facultad de Ciencias Veterinarias y Pecuarias, Universidad de Chile, Chile
| | - Norbel Galanti
- Programa Disciplinario de Inmunología, Programa de Genética Humana, Programa de Biología Celular y Molecular, Instituto de Ciencias Biomédicas; Laboratorio de Análisis de Imágenes Científicas (SCIAN), Instituto de Neurociencias Biomédicas, Facultad de Medicina; Departamento de Medicina Preventiva Animal, Departamento de Ciencias Biológicas Animales, Facultad de Ciencias Veterinarias y Pecuarias, Universidad de Chile, Chile
| | - Arturo Ferreira
- Programa Disciplinario de Inmunología, Programa de Genética Humana, Programa de Biología Celular y Molecular, Instituto de Ciencias Biomédicas; Laboratorio de Análisis de Imágenes Científicas (SCIAN), Instituto de Neurociencias Biomédicas, Facultad de Medicina; Departamento de Medicina Preventiva Animal, Departamento de Ciencias Biológicas Animales, Facultad de Ciencias Veterinarias y Pecuarias, Universidad de Chile, Chile
| |
Collapse
|
7
|
Ramírez-Toloza G, Aguilar-Guzmán L, Valck C, Abello P, Ferreira A. Is it all That Bad When Living with an Intracellular Protozoan? The Role of Trypanosoma cruzi Calreticulin in Angiogenesis and Tumor Growth. Front Oncol 2015; 4:382. [PMID: 25629005 PMCID: PMC4292450 DOI: 10.3389/fonc.2014.00382] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2014] [Accepted: 12/19/2014] [Indexed: 10/28/2022] Open
Abstract
The immune system protects against disease, but may aberrantly silence immunity against "altered self," with consequent development of malignancies. Among the components of the endoplasmic reticulum (ER), important in immunity, is calreticulin (CRT) that, in spite of its residence in the ER, can be translocated to the exterior. Trypanosoma cruzi is the agent of Chagas disease, one of the most important global neglected infections, affecting several hundred thousand people. The syndrome, mainly digestive and circulatory, affects only one-third of those infected. The anti-tumor effects of the infection are known for several decades, but advances in the identification of responsible T. cruzi molecules are scarce. We have shown that T. cruzi CRT (TcCRT) better executes the antiangiogenic and anti-tumor effects of mammal CRT and its N-terminus vasostatin. In this regard, recombinant TcCRT (rTcCRT) and/or its N-terminus inhibit angiogenesis in vitro, ex vivo, and in vivo. TcCRT also inhibits the growth of murine adenocarcinomas and melanomas. Finally, rTcCRT fully reproduces the anti-tumor effect of T. cruzi infection in mice. Thus, we hypothesize that, the long reported anti-tumor effect of T. cruzi infection is mediated at least in part by TcCRT.
Collapse
Affiliation(s)
- Galia Ramírez-Toloza
- Faculty of Veterinary Medicine and Livestock Sciences, University of Chile , Santiago , Chile
| | - Lorena Aguilar-Guzmán
- Faculty of Veterinary Medicine and Livestock Sciences, University of Chile , Santiago , Chile
| | - Carolina Valck
- Program of Immunology, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile , Santiago , Chile
| | - Paula Abello
- Program of Immunology, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile , Santiago , Chile
| | - Arturo Ferreira
- Program of Immunology, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile , Santiago , Chile
| |
Collapse
|
8
|
Ribeiro CH, Lynch NJ, Stover CM, Ali YM, Valck C, Noya-Leal F, Schwaeble WJ, Ferreira A. Deficiency in mannose-binding lectin-associated serine protease-2 does not increase susceptibility to Trypanosoma cruzi infection. Am J Trop Med Hyg 2014; 92:320-4. [PMID: 25548381 DOI: 10.4269/ajtmh.14-0236] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
Trypanosoma cruzi is the causative agent of Chagas' disease, a chronic illness affecting 10 million people around the world. The complement system plays an important role in fighting microbial infections. The recognition molecules of the lectin pathway of complement activation, mannose-binding lectin (MBL), ficolins, and CL-11, bind to specific carbohydrates on pathogens, triggering complement activation through MBL-associated serine protease-2 (MASP-2). Previous in vitro work showed that human MBL and ficolins contribute to T. cruzi lysis. However, MBL-deficient mice are only moderately compromised in their defense against the parasite, as they may still activate the lectin pathway through ficolins and CL-11. Here, we assessed MASP-2-deficient mice, the only presently available mouse line with total lectin pathway deficiency, for a phenotype in T. cruzi infection. Total absence of lectin pathway functional activity did not confer higher susceptibility to T. cruzi infection, suggesting that it plays a minor role in the immune response against this parasite.
Collapse
Affiliation(s)
- Carolina H Ribeiro
- Programa Disciplinario de Inmunología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom; Department of Microbiology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt
| | - Nicholas J Lynch
- Programa Disciplinario de Inmunología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom; Department of Microbiology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt
| | - Cordula M Stover
- Programa Disciplinario de Inmunología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom; Department of Microbiology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt
| | - Youssif M Ali
- Programa Disciplinario de Inmunología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom; Department of Microbiology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt
| | - Carolina Valck
- Programa Disciplinario de Inmunología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom; Department of Microbiology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt
| | - Francisca Noya-Leal
- Programa Disciplinario de Inmunología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom; Department of Microbiology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt
| | - Wilhelm J Schwaeble
- Programa Disciplinario de Inmunología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom; Department of Microbiology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt
| | - Arturo Ferreira
- Programa Disciplinario de Inmunología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom; Department of Microbiology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt
| |
Collapse
|
9
|
Sosoniuk E, Vallejos G, Kenawy H, Gaboriaud C, Thielens N, Fujita T, Schwaeble W, Ferreira A, Valck C. Trypanosoma cruzi calreticulin inhibits the complement lectin pathway activation by direct interaction with L-Ficolin. Mol Immunol 2014; 60:80-5. [PMID: 24769495 DOI: 10.1016/j.molimm.2014.03.014] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2014] [Accepted: 03/25/2014] [Indexed: 10/25/2022]
Abstract
Trypanosoma cruzi, the agent of Chagas' disease, the sixth neglected tropical disease worldwide, infects 10-12 million people in Latin America. Differently from T. cruzi epimastigotes, trypomastigotes are complement-resistant and infective. CRPs, T-DAF, sialic acid and lipases explain at least part of this resistance. In vitro, T. cruzi calreticulin (TcCRT), a chaperone molecule that translocates from the ER to the parasite surface: (a) Inhibits the human classical complement activation, by interacting with C1, (b) As a consequence, an increase in infectivity is evident and, (c) It inhibits angiogenesis and tumor growth. We report here that TcCRT also binds to the L-Ficolin collagenous portion, thus inhibiting approximately between 35 and 64% of the human complement lectin pathway activation, initiated by L-Ficolin, a property not shared by H-Ficolin. While L-Ficolin binds to 60% of trypomastigotes and to 24% of epimastigotes, 50% of the former and 4% of the latter display TcCRT on their surfaces. Altogether, these data indicate that TcCRT is a parasite inhibitory receptor for Ficolins. The resulting evasive activities, together with the TcCRT capacity to inhibit C1, with a concomitant increase in infectivity, may represent T. cruzi strategies to inhibit important arms of the innate immune response.
Collapse
Affiliation(s)
- Eduardo Sosoniuk
- Programa de Inmunología, ICBM, Facultad de Medicina, Universidad de Chile, Santiago, Chile
| | - Gerardo Vallejos
- Programa de Inmunología, ICBM, Facultad de Medicina, Universidad de Chile, Santiago, Chile
| | - Hany Kenawy
- Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK; Department of Microbiology and Immunology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt
| | - Christine Gaboriaud
- CNRS, Institut de Biologie Structurale JP Ebel, Grenoble, France; Université Joseph Fourier, Institut de Biologie Structurale JP Ebel, Grenoble, France
| | - Nicole Thielens
- CNRS, Institut de Biologie Structurale JP Ebel, Grenoble, France; Université Joseph Fourier, Institut de Biologie Structurale JP Ebel, Grenoble, France
| | - Teizo Fujita
- Department of Immunology, Fukushima Medical University, Fukushima, Japan
| | - Wilhelm Schwaeble
- Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK
| | - Arturo Ferreira
- Programa de Inmunología, ICBM, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
| | - Carolina Valck
- Programa de Inmunología, ICBM, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
| |
Collapse
|
10
|
Castillo C, Ramírez G, Valck C, Aguilar L, Maldonado I, Rosas C, Galanti N, Kemmerling U, Ferreira A. The interaction of classical complement component C1 with parasite and host calreticulin mediates Trypanosoma cruzi infection of human placenta. PLoS Negl Trop Dis 2013; 7:e2376. [PMID: 23991234 PMCID: PMC3749977 DOI: 10.1371/journal.pntd.0002376] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2013] [Accepted: 07/03/2013] [Indexed: 01/28/2023] Open
Abstract
Background 9 million people are infected with Trypanosoma cruzi in Latin America, plus more than 300,000 in the United States, Canada, Europe, Australia, and Japan. Approximately 30% of infected individuals develop circulatory or digestive pathology. While in underdeveloped countries transmission is mainly through hematophagous arthropods, transplacental infection prevails in developed ones. Methodology/Principal Findings During infection, T. cruzi calreticulin (TcCRT) translocates from the endoplasmic reticulum to the area of flagellum emergence. There, TcCRT acts as virulence factor since it binds maternal classical complement component C1q that recognizes human calreticulin (HuCRT) in placenta, with increased parasite infectivity. As measured ex vivo by quantitative PCR in human placenta chorionic villi explants (HPCVE) (the closest available correlate of human congenital T. cruzi infection), C1q mediated up to a 3–5-fold increase in parasite load. Because anti-TcCRT and anti-HuCRT F(ab′)2 antibody fragments are devoid of their Fc-dependent capacity to recruit C1q, they reverted the C1q-mediated increase in parasite load by respectively preventing its interaction with cell-bound CRTs from both parasite and HPCVE origins. The use of competing fluid-phase recombinant HuCRT and F(ab′)2 antibody fragments anti-TcCRT corroborated this. These results are consistent with a high expression of fetal CRT on placental free chorionic villi. Increased C1q-mediated infection is paralleled by placental tissue damage, as evidenced by histopathology, a damage that is ameliorated by anti-TcCRT F(ab′)2 antibody fragments or fluid-phase HuCRT. Conclusions/Significance T. cruzi infection of HPCVE is importantly mediated by human and parasite CRTs and C1q. Most likely, C1q bridges CRT on the parasite surface with its receptor orthologue on human placental cells, thus facilitating the first encounter between the parasite and the fetal derived placental tissue. The results presented here have several potential translational medicine aspects, specifically related with the capacity of antibody fragments to inhibit the C1q/CRT interactions and thus T. cruzi infectivity. The Trypanosoma cruzi protozoan infects 9 million people in Latin America and increasing numbers in North America, Europe, Australia, and Japan. It is an important neglected parasitic disease in the Americas with no safe treatment available. One third of those infected develops incapacitating pathology. While in poor countries transmission of the parasite is mainly through blood feeding insects, transplacental infection is increasingly important in developed regions. Herein we show that T. cruzi calreticulin (TcCRT), a multifunctional protein, exteriorized by the parasite, mediates infection of human placenta, since it binds human complement component C1, a “danger signal” detector. (Complement is an innate immune defense system, with more than 40 plasma or membrane-bound proteins). However, in a parasite strategy, maternal C1 is utilized to infect placenta. Fetal calreticulin (HuCRT) is also easily detectable in placental tissues that are in direct contact with maternal blood. Thus, C1q by bridging parasite and HuCRT mediates high increases in cultured placental tissue infection with damaging consequences. Complete reversion of C1-mediated infection and a decreased placental damage, is observed in the presence of anti-TcCRT and anti-HuCRT antibody fragments, or fluid-phase competing HuCRT. It remains to be determined whether these mechanisms also operate in other intracellular protozoa.
Collapse
Affiliation(s)
- Christian Castillo
- Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago, Chile
| | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Ferreira A, Castillo C, Duaso J, Maldonado I, Valck C, Rosas C, Aguilar L, Ramirez G, Galanti N, Kemmerling U. The interaction of classical complement component C1 with parasite and host calreticulin mediates Trypanosoma cruzi infection of human placenta (P3062). The Journal of Immunology 2013. [DOI: 10.4049/jimmunol.190.supp.125.9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Abstract
13 million people are infected with Trypanosoma cruzi in Latin America, plus more than 300,000 in the USA, Canada, Europe, Australia, and Japan. An important number develops circulatory or digestive syndromes. While in poor countries transmission is mainly through arthropod vectors, transplacental infection prevails in developed ones. T. cruzi calreticulin (TcCRT) translocates from the endoplasmic reticulum to the area of flagellum emergence, acting as a virulence factor because it binds maternal complement C1. As measured by qPCR in human placenta chorionic villi explants (HPCVE), C1q mediated up to a 4-fold increase in infectivity. Because anti-TcCRT and anti-HuCRT F(ab')2 antibody fragments are devoid of their Fc-dependent capacity to recruit C1q, they completely reverted the C1q-mediated infectivity by respectively preventing its interaction with cell-bound parasite and HPCVE CRTs. This was corroborated by using competing fluid-phase recombinant TcCRT or human CRT and by a high expression of fetal CRT on free villi. Increased C1q-mediated infection is paralleled by fetal syncytiotrophoblast damage, that is reverted by anti-TcCRT F(ab')2 fragments or fluid-phase HuCRT. Most likely, C1q bridges CRT on the parasite with its placenta orthologue, thus facilitating their first encounter. The placental explants assay used in these studies is the closest ex vivo available correlate now revealing a plausible new mechanism of human congenital T. cruzi infection.
Collapse
Affiliation(s)
- Arturo Ferreira
- 1Institute of Biomedical Sciences, ICBM, Faculty of Medicine, University of Chile, Santiago, Chile
| | - Christian Castillo
- 1Institute of Biomedical Sciences, ICBM, Faculty of Medicine, University of Chile, Santiago, Chile
| | - Juan Duaso
- 1Institute of Biomedical Sciences, ICBM, Faculty of Medicine, University of Chile, Santiago, Chile
| | - Ismael Maldonado
- 1Institute of Biomedical Sciences, ICBM, Faculty of Medicine, University of Chile, Santiago, Chile
| | - Carolina Valck
- 1Institute of Biomedical Sciences, ICBM, Faculty of Medicine, University of Chile, Santiago, Chile
| | - Carlos Rosas
- 1Institute of Biomedical Sciences, ICBM, Faculty of Medicine, University of Chile, Santiago, Chile
| | - Lorena Aguilar
- 1Institute of Biomedical Sciences, ICBM, Faculty of Medicine, University of Chile, Santiago, Chile
| | - Galia Ramirez
- 2Department of Preventive Animal Medicine, Faculty of Veterinary Medicine, University of Chile, Santiago, Chile
| | - Norbel Galanti
- 1Institute of Biomedical Sciences, ICBM, Faculty of Medicine, University of Chile, Santiago, Chile
| | - Ulrike Kemmerling
- 1Institute of Biomedical Sciences, ICBM, Faculty of Medicine, University of Chile, Santiago, Chile
| |
Collapse
|
12
|
Castillo C, Duaso J, Maldonado I, Ramírez G, Valck C, Kemmerling U, Ferreira A. C1 interaction with Trypanosoma cruzi calreticulin mediates ex vivo infection of human placenta. Immunobiology 2012. [DOI: 10.1016/j.imbio.2012.08.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
13
|
Abello P, Maldonado I, Ramírez G, Hidalgo H, Ferreira A, Valck C. Trypanosoma cruzi calreticulin inhibits the classical pathway of complement activation in Gallus gallus. Immunobiology 2012. [DOI: 10.1016/j.imbio.2012.08.246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
14
|
Ramírez G, Valck C, Aguilar L, Kemmerling U, López-Muñoz R, Cabrera G, Morello A, Ferreira J, Maya JD, Galanti N, Ferreira A. Roles of Trypanosoma cruzi calreticulin in parasite-host interactions and in tumor growth. Mol Immunol 2012; 52:133-40. [PMID: 22673211 DOI: 10.1016/j.molimm.2012.05.006] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2012] [Revised: 05/05/2012] [Accepted: 05/07/2012] [Indexed: 12/14/2022]
Abstract
In Latin America, there are about 10-12 million people infected with Trypanosoma cruzi, the agent of Chagas' disease, one of the most important neglected tropical parasitism. Identification of molecular targets, specific for the aggressor or host cells or both, may be useful in the development of pharmacological and/or immunological therapeutic tools. Classic efforts in Chagas' disease explore those strategies. Although the immune system frequently controls parasite aggressions, sterile immunity is seldom achieved and chronic interactions are thus established. However, laboratory-modified immunologic probes aimed at selected parasite targets, may be more effective than their unmodified counterparts. Calreticulin (CRT) from vertebrates is a calcium binding protein, present mainly in the endoplasmic reticulum (ER), where it directs the conformation of proteins and controls calcium levels. We have isolated, gene-cloned, expressed and characterized T. cruzi calreticulin (TcCRT). Upon infection, the parasite can translocate this molecule from the ER to the surface, where it inhibits both the classical and lectin complement pathways. Moreover, by virtue of its capacity to bind and inactivate first complement component C1, it promotes parasite infectivity. These two related properties reside in the central domain of this molecule. A different domain, amino terminal, binds to endothelial cells, thus inhibiting their angiogenic capacity. Since tumor growth depends, to a large extent on angiogenesis, their growth is also inhibited.
Collapse
Affiliation(s)
- Galia Ramírez
- Department of Preventive Animal Medicine, University of Chile, Santiago, Chile
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Ramírez G, Valck C, Ferreira VP, López N, Ferreira A. Extracellular Trypanosoma cruzi calreticulin in the host-parasite interplay. Trends Parasitol 2011; 27:115-22. [PMID: 21288773 DOI: 10.1016/j.pt.2010.12.007] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2010] [Revised: 12/18/2010] [Accepted: 12/20/2010] [Indexed: 11/24/2022]
Abstract
Calreticulin (CRT) from vertebrates is a calcium-binding protein present mainly in the endoplasmic reticulum (ER). There, it directs the conformation of proteins and controls calcium levels. This review will focus on several extracellular roles of Trypanosoma cruzi CRT (TcCRT) in relation to its capacity to inhibit the complement system, mediate parasite infectivity, interfere with angiogenesis and, as a possible consequence, with tumor growth. The TcCRT antiangiogenic effect parallels with the capacity of T. cruzi infection to inhibit tumor development in vivo. Thus, the TcCRT, complement, and endothelial cell interactions seem to be an evolutionary adaptation to promote prolonged parasite-host relationships.
Collapse
Affiliation(s)
- Galia Ramírez
- Programa Disciplinario de Inmunología, ICBM, Facultad de Medicina, Universidad de Chile, Independencia 1027, Santiago, Chile
| | | | | | | | | |
Collapse
|
16
|
Toledo V, Ramírez G, Valck C, López N, Ribeiro CH, Maldonado I, Aguilar L, Lemus D, Ferreira A. Comparative in vivo antiangiogenic effects of calreticulin from Trypanosoma cruzi and Homo sapiens sapiens. Biol Res 2010; 43:287-289. [PMID: 21249299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023] Open
Abstract
Angiogenesis is a complex multi-step process of neovascularization arising from preexisting blood vessels whose generation is regulated by pro- and anti-angiogenic factors. Both Trypanosoma cruzi calreticulin (TcCRT) and its human counterpart (HuCRT) are antiangiogenic. This is the first report where the TcCRT and HuCRT anti-angiogenic properties are compared in vivo. In the chick embryonic chorioallantoid membrane assay (CAM) and at equimolar concentrations, TcCRT displayed significantly higher antiangiogenic activities than its human counterpart. LPS had marginal effects at the concentrations present in the recombinant protein preparations and the TcCRT antiangiogenic effects were largely inhibited by specific polyclonal antibodies, thus, reinforcing the fact that the observed TcCRT effects can be attributed to the parasite-derived molecule and not to the endotoxin. The antiangiogenic TcCRT effects correlate with its anti-tumor in vivo effects, as recently shown in our laboratory.
Collapse
Affiliation(s)
- Victor Toledo
- Laboratory of Immunology of Microbial Aggression, Immunology Disciplinary Program, ICBM, Faculty of Medicine, University of Chile, Independence, Santiago, Chile
| | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Ramírez G, Valck C, Molina M, Ribeiro C, López N, Sánchez G, Maldonado I, Ferreira V, Schwaeble W, Ferreira A. Trypanosoma cruzi calreticulin, a virulence factor that binds C1/C1q on the parasite surface. Mol Immunol 2010. [DOI: 10.1016/j.molimm.2010.05.150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
18
|
Ferreira A, Ramírez G, Sánchez G, Ribeiro C, López N, Maldonado I, Fujita T, Schwaeble W, Valck C. Trypanosoma cruzi calreticulin inhibits the complement lectin pathway activation by direct interaction with l-Ficolin. Mol Immunol 2010. [DOI: 10.1016/j.molimm.2010.05.203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
19
|
Toledo V, Ramírez G, Valck C, López N, Ribeiro CH, Maldonado I, Aguilar L, Lemus D, Ferreira A. Comparative in vivo antiangiogenic effects of calreticulin from Trypanosoma cruzi and Homo sapiens sapiens. Biol Res 2010. [DOI: 10.4067/s0716-97602010000300004] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
20
|
Molina MC, Ferreira V, Valck C, Aguilar L, Orellana J, Rojas A, Ramirez G, Billetta R, Schwaeble W, Lemus D, Ferreira A. An in vivo role for Trypanosoma cruzi calreticulin in antiangiogenesis. Mol Biochem Parasitol 2005; 140:133-40. [PMID: 15760653 DOI: 10.1016/j.molbiopara.2004.12.014] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2004] [Revised: 11/25/2004] [Accepted: 12/05/2004] [Indexed: 11/21/2022]
Abstract
Angiogenesis leads to neovascularization from existing blood vessels. It is associated with tumor growth and metastasis and is regulated by pro- and antiangiogenic molecules, some of them currently under clinical trials for cancer treatment. During the last few years we have cloned, sequenced and expressed a Trypanosoma cruzi calreticulin gene (TcCRT). Its product, TcCRT, a 45 kDa protein, is more than 50% identical to human CRT (HuCRT). TcCRT, present on the surface of trypomastigotes, binds both C1q and mannan binding lectin and inhibits the classical activation pathway of human complement. Since TcCRT is highly homologous to a functional antiangiogenic fragment from HuCRT (aa 120-180), recombinant (r) and native (n) TcCRT were tested in their antiangiogenic effects, in the chick embryonic chorioallantoid membrane (CAM) assay. Both proteins mediated highly significant antiangiogenic effects in the in vivo CAM assay. This effect was further substantiated in experiments showing that the plasmid construct pSecTag/TcCRT also displayed significant antiangiogenic properties, as compared to the empty vector. Most likely, the fact that antiangiogenic substances act preferentially on growing neoplasic tissues, but not on already established tumors, is due to their effects on emerging blood vessels. The results shown here indicate that TcCRT, like its human counterpart, has antiangiogenic properties. These properties may explain, at least partly, the reported antineoplasic effect of experimental T. cruzi infection.
Collapse
Affiliation(s)
- María C Molina
- Programa Disciplinario de Inmunología, ICBM, Facultad de Medicina, Universidad de Chile, Independencia, 1027 Santiago, Chile
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Aguilar L, Ramírez G, Valck C, Molina MC, Rojas A, Schwaeble W, Ferreira V, Ferreira A. F(ab')2 antibody fragments against Trypanosoma cruzi calreticulin inhibit its interaction with the first component of human complement. Biol Res 2005; 38:187-95. [PMID: 16238097 DOI: 10.4067/s0716-97602005000200008] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Trypanosoma cruzi calreticulin (TcCRT), described in our laboratory, retains several important functional features from its vertebrate homologues. We have shown that recombinant TcCRT inhibits the human complement system when it binds to the collagenous portion of C1q. The generation of classical pathway convertases and membrane attack complexes is thus strongly inhibited. In most T. cruzi-infected individuals, TcCRT is immunogenic and mediates the generation of specific antibodies. By reverting the C1q / TcCRT interaction, a parasite immune evasion strategy, these antibodies contribute to the host/parasite equilibrium. In an in vitro correlate of this situation, we show that the Clq/TcCRT interaction is inhibited by F(ab')2 polyclonal anti-TcCRT IgG fragments. It is therefore feasible that in infected humans anti-TcCRT antibodies participate in reverting an important parasite strategy aimed at inhibiting the classical complement pathway. Thus, membrane-bound TcCRT interacts with the collagenous portion Clq, and this Clq is recognized by the CD91-bound host cell CRT, thus facilitating parasite internalization. Based on our in vitro results, it could be proposed that the in vivo interaction between TcCRT and vertebrate Clq could be inhibited by F(ab')2 fragments anti-rTcCRT or against its S functional domain, thus interfering with the internalization process.
Collapse
Affiliation(s)
- Lorena Aguilar
- Immunology Disciplinary Program, ICBM, Faculty of Medicine, Universidad de Chile, Santiago, Chile
| | | | | | | | | | | | | | | |
Collapse
|
22
|
Ferreira V, Valck C, Sánchez G, Gingras A, Tzima S, Molina MC, Sim R, Schwaeble W, Ferreira A. The classical activation pathway of the human complement system is specifically inhibited by calreticulin from Trypanosoma cruzi. J Immunol 2004; 172:3042-50. [PMID: 14978109 DOI: 10.4049/jimmunol.172.5.3042] [Citation(s) in RCA: 94] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
The high resistance of Trypanosoma cruzi trypomastigotes, the causal agent of Chagas' disease, to complement involves several parasite strategies. In these in vitro studies, we show that T. cruzi calreticulin (TcCRT) and two subfragments thereof (TcCRT S and TcCRT R domains) bind specifically to recognition subcomponents of the classical and lectin activation pathways (i.e., to collagenous tails of C1q and to mannan-binding lectin) of the human complement system. As a consequence of this binding, specific functional inhibition of the classical pathway and impaired mannan-binding lectin to mannose were observed. By flow cytometry, TcCRT was detected on the surface of viable trypomastigotes and, by confocal microscopy, colocalization of human C1q with surface TcCRT of infective trypomastigotes was visualized. Taken together, these findings imply that TcCRT may be a critical factor contributing to the ability of trypomastigotes to interfere at the earliest stages of complement activation.
Collapse
Affiliation(s)
- Viviana Ferreira
- Immunology and Molecular Biology Disciplinary Programs, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago, Chile
| | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Ferreira V, Molina MC, Valck C, Rojas A, Aguilar L, Ramírez G, Schwaeble W, Ferreira A. Role of calreticulin from parasites in its interaction with vertebrate hosts. Mol Immunol 2004; 40:1279-91. [PMID: 15128045 DOI: 10.1016/j.molimm.2003.11.018] [Citation(s) in RCA: 71] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Although parasites range from protozoan to complex, evolutionary advanced arthropods, in general, a hallmark of parasite life cycles is their ability to adapt to changes in temperature, pH and host defense strategies. Calreticulin, a calcium-binding protein, highly conserved and multifunctional, is present in every cell of higher organisms, except erythrocytes. The surprising array of calreticulin-associated functions include lectin-like chaperoning, calcium storage and signaling, modulation of gene expression, cell adhesion, enhancement of phagocytosis of C1q or collectin opsonized apoptotic cells, inhibition of angiogenesis and tumoral growth, inhibition of perforin pore formation in T and NK cells, and inhibition of C1q-dependent complement activation. Likewise, calreticulin is present in a wide spectrum of sub cellular compartments. Parasite calreticulin shows a surprisingly high degree of conservation within the framework of its functional domains. Its role within the parasite/host relationship needs to be assessed further, in particular with regard to its impact on parasite infectivity, by helping to evade from its hosts' immune response. With special emphasis on calreticulin from Trypanosoma cruzi, the intracellular protozoan agent of American trypanosomiasis (Chagas' disease), we wish to exemplify and highlight the various implications of parasite calreticulin, within the pathophysiology of parasite-mediated human and animal disease.
Collapse
Affiliation(s)
- Viviana Ferreira
- Programa de Immunología, ICBM, Facultad de Medicina, Universidad de Chile, Santiago, Chile
| | | | | | | | | | | | | | | |
Collapse
|